SEC Form 4 · accession 0001628280-18-005728
NeuroMetrix, Inc. · NURO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Van Avermaete
Director
Period of report
May 1, 2018
Accepted (ET)
May 2, 2018 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001289850
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F1 | $1.39 | May 1, 2018 | A | 5,000 | A | — | May 1, 2028 | Common Stock | 5,000 | 17,252 | D |
Explanation of responses
- F1This option vests as follows: 25% on May 1, 2019, and 1/16 each quarter thereafter